Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for Neuroprotection in Neonatal Cardiac Surgery
NCT00513240Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2006
- Primary completion
- Sep 2012
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in traumatic brain injury (TBI), sponsored by Baylor College of Medicine. Started Sep 2006; status: completed.
02
Drugs
epoetin alfa
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT00513240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513240.